Mutation screening of PDZD2, GOLPH3, and MTMR12 genes in patients with schizophrenia.
Mutation screening of PDZD2, GOLPH3, and MTMR12 genes in patients with schizophrenia.
复制标题
精神分裂症患者PDZD2、GOLPH3、MTMR12基因突变筛查。
DOI:
10.1097/ypg.0b013e3283463dd7
复制
发表时间:
2012
影响因子:
0.9
通讯作者:
Bespalova,IrinaN
中科院分区:
文献类型:
--
作者:
Ritter,BenjaminP;Angelo,GaryW;Durner,Martina;Rossy-Fullana,Enrique;Carrion-Baralt,Jose;Silverman,JeremyM;Bespalova,IrinaN
We earlier identified a region on chromosome 5p13 associated with schizophrenia in a large Puerto Rican pedigree from a genetic isolate of Spanish origin (Silverman et al., 1996). Using a whole genome scan followed by fine mapping, we narrowed the minimal linkage region (MLR) to 2.8 Mb, and detected the ‘at-risk’haplotype shared by all affected members of the family (Bespalova et al., 2005). The MLR contains 13 annotated genes. In this study, we carried out mutation analysis of three genes from the telomeric region of the MLR in affected members of the pedigree: the PDZ domain-containing protein (PDZD2), the golgi phosphoprotein (GOLPH3), and the myotubularin related protein (MTMR12).The PDZD2 gene is expressed in several tissues including the brain. The encoded protein is involved in synaptic transmission in the central nervous system, and may influence stability and function of γ-aminobutyric acidtype B associated with schizophrenia (Mizukami et al., 2002; Balasubramanian et al., 2007). The increased amount of the GOLPH3-encoded protein was found in human cell line derived from cervical cancer cells during a mitochondrial dysfunction, which was reported in schizophrenia by several studies (Nakashima-Kamimura et al., 2005; Wood et al., 2009). The function of the MTMR12 gene is unknown.